(MENAFN– Costa Rica News)
After analyzing more than 100 topical cannabidiol (CBD) products sold in stores and online, Johns Hopkins Medicine researchers have found that the CBD content claim on labels is significantly inaccurate and misleading . Furthermore, the results of the study have not only shown that some of these over-the-counter products contain delta-9-tetrahydrocannabinol (THC), the main component of cannabis that causes the“high”, but that this substance it is present in some products where it is expressly stated that they do not contain it.
The study, published on July 20th in the scientific journal JAMA Network Open, has revealed that even some CBD products claim to have therapeutic properties that the US Food and Drug Administration (FDA) has not endorsed. To date, the FDA has only authorized one prescription-only CBD product to treat seizures associated with rare epileptic disorders, and two prescription-only THC products to treat nausea and vomiting caused by chemotherapy and symptoms of loss of appetite and weight loss associated with HIV and AIDS.
“Labels with inaccurate and misleading information, instead of promoting the consumption of products authorized by the FDA, which are safe and effective for the treatment of specific conditions, lead to the consumption of expensive and barely regulated CBD products,” explains one of study authors Dr. Tory Spindle, associate professor of psychiatry and…
Original Author Link click here to read complete story..
